Tonix Pharmaceuticals Hldg C

CUSIP 890260847COM NEWQ1 2025

Tonix Pharmaceuticals Hldg C — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 14, 2025	L1 Capital Global Opportunities Master Fund, Ltd.	13G/A	—	—	SEC
2	Nov 14, 2024	Armistice Capital, LLC	13G/A	0.8%	1.50M	SEC
3	Oct 16, 2024	Empery Asset Management, LP	13G/A	1.3%	1.74M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Ifp Advisors, Inc	10.0K	$1.5K